GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET FORECAST 2017-2025
KEY FINDINGS
The postpartum hemorrhage treatment device market size is poised to expand to $1155 million by 2025, at a CAGR of 6.57% between 2017 and 2025. The base year considered for the postpartum hemorrhage treatment device market report is 2016 and the forecast period is from 2017 to 2025. Rise in the awareness in developing countries among people for postpartum treatment, growing occurrence of postpartum hemorrhage and increase in the government educational initiatives and training about women health are the main factors driving the global postpartum hemorrhage treatment device market.
MARKET INSIGHTS
The global postpartum hemorrhage treatment device market is segmented on the basis of type and by geography. The global postpartum hemorrhage market by type is further bifurcated into uterine balloon tamponade market, uniject prefilled injection system and nonpneumatic antishock garment. The uterine balloon tamponade market type is further segmented into global foley catheters market, global condom catheters market and global others market. The segment of geography in global postpartum hemorrhage market is classified into North America, Europe, Asia-Pacific and rest of the world. Rise in the awareness in people in the developing countries for postpartum treatment, growth in the occurrence of postpartum hemorrhage, conception in postpartum hemorrhage, risk factor and increase in the government initiatives and training about women health are leading the growth of the global postpartum hemorrhage market.
REGIONAL INSIGHTS
The postpartum hemorrhage treatment device market in North America is expected to hold the largest share by 2025. The increase in the occurrence of PPH across North America, growth in the alertness among patients coupled with advanced healthcare service providers, improved hospital delivery rates, as well as viable accessibility of treatment devices are some of the factors driving excellent demand from the North American PPH treatment devices market. After the US and Canada, UK and Germany are estimated to be the developing markets for the postpartum hemorrhage treatment device. The mentioned countries are expected to adopt most of the technological developments, compared to other geographic regions.
COMPETITIVE INSIGHTS
Major players in the postpartum hemorrhage treatment device market are 3rd Stone Design Inc, Bactiguard AB, C.R.BardInc, Cook Medical Inc, DavolInc, Teleflex Incorporated, Utah Medical Products Inc, Becton Dickinson and Company, GE Healthcare, and Program for Appropriate Technology In Health (PATH), ZoexNiasg, and Inpress Technologies.
The postpartum hemorrhage treatment device market size is poised to expand to $1155 million by 2025, at a CAGR of 6.57% between 2017 and 2025. The base year considered for the postpartum hemorrhage treatment device market report is 2016 and the forecast period is from 2017 to 2025. Rise in the awareness in developing countries among people for postpartum treatment, growing occurrence of postpartum hemorrhage and increase in the government educational initiatives and training about women health are the main factors driving the global postpartum hemorrhage treatment device market.
MARKET INSIGHTS
The global postpartum hemorrhage treatment device market is segmented on the basis of type and by geography. The global postpartum hemorrhage market by type is further bifurcated into uterine balloon tamponade market, uniject prefilled injection system and nonpneumatic antishock garment. The uterine balloon tamponade market type is further segmented into global foley catheters market, global condom catheters market and global others market. The segment of geography in global postpartum hemorrhage market is classified into North America, Europe, Asia-Pacific and rest of the world. Rise in the awareness in people in the developing countries for postpartum treatment, growth in the occurrence of postpartum hemorrhage, conception in postpartum hemorrhage, risk factor and increase in the government initiatives and training about women health are leading the growth of the global postpartum hemorrhage market.
REGIONAL INSIGHTS
The postpartum hemorrhage treatment device market in North America is expected to hold the largest share by 2025. The increase in the occurrence of PPH across North America, growth in the alertness among patients coupled with advanced healthcare service providers, improved hospital delivery rates, as well as viable accessibility of treatment devices are some of the factors driving excellent demand from the North American PPH treatment devices market. After the US and Canada, UK and Germany are estimated to be the developing markets for the postpartum hemorrhage treatment device. The mentioned countries are expected to adopt most of the technological developments, compared to other geographic regions.
COMPETITIVE INSIGHTS
Major players in the postpartum hemorrhage treatment device market are 3rd Stone Design Inc, Bactiguard AB, C.R.BardInc, Cook Medical Inc, DavolInc, Teleflex Incorporated, Utah Medical Products Inc, Becton Dickinson and Company, GE Healthcare, and Program for Appropriate Technology In Health (PATH), ZoexNiasg, and Inpress Technologies.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. MARKET DRIVERS
4.2.1. RISING AWARENESS AMONG PEOPLE IN DEVELOPING COUNTRIES FOR POSTPARTUM TREATMENT
4.2.2. RISING OCCURRENCE OF POSTPARTUM HEMORRHAGE
4.2.3. PROLIFERATION IN POSTPARTUM HEMORRHAGE RISK FACTORS
4.2.4. INCREASING GOVERNMENT EDUCATIONAL INITIATIVES AND TRAINING ABOUT WOMEN’S HEALTH
4.3. MARKET RESTRAINTS
4.3.1. PEOPLE ARE RELUCTANT TO ADOPT UNCONVENTIONAL POSTPARTUM HEMORRHAGE PREVENTIVE DEVICES
4.4. MARKET OPPORTUNITIES
4.4.1. RISING DEMAND FROM EMERGING COUNTRIES
4.4.2. TECHNOLOGICAL ADVANCEMENTS
4.5. MARKET CHALLENGES
4.5.1. LOW ACCEPTANCE OF DEVICES IN DEVELOPING COUNTRIES
4.5.2. LACK OF PRODUCT AWARENESS IN UNTAPPED MARKET
4.5.3. EASY AVAILABILITY OF DRUGS IN THE MARKET
5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($ MILLION)
5.1. BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
5.1.1. GLOBAL FOLEY CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.2. GLOBAL CONDOM CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.3. GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)
5.2. BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
5.3. BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.2.1. PRICING
6.2.2. AVAILABILITY
6.2.3. QUALITY
6.2.4. SPECIFICITY
6.3. OPPORTUNITY MATRIX
6.4. VENDOR LANDSCAPE
7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANAD
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. ITALY
7.2.6. ROE
7.3. ASIA PACIFIC
7.3.1. INDIA
7.3.2. CHINA
7.3.3. JAPAN
7.3.4. SOUTH KOREA
7.3.5. ROAPAC
7.4. REST OF THE WORLD
7.4.1. LATIN AMERICA
7.4.2. MENA
7.4.3. REST OF AFRICA
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. LIST OF STRAGETIC INITIATIVES
8.3. COMPANY PROFILES
8.3.1. 3RD STONE DESIGN, INC.
8.3.1.1. OVERVIEW
8.3.1.2. PRODUCT PORTFOLIO:
8.3.1.3. SCOT ANALYSIS
8.3.1.4. STRATEGIC ANALYSIS
8.3.2. BACTIGUARD AB
8.3.2.1. OVERVIEW
8.3.2.2. PRODUCT PORTFOLIO:
8.3.2.3. STRATEGIC INITIATIVES:
8.3.2.4. SCOT ANALYSIS
8.3.2.5. STRATEGIC ANALYSIS
8.3.3. C. R. BARD, INC.
8.3.3.1. OVERVIEW
8.3.3.2. PRODUCT PORTFOLIO
8.3.3.3. STRATEGIC INITIATIVES:
8.3.3.4. SCOT ANALYSIS
8.3.3.5. STRATEGIC ANALYSIS
8.3.4. COOK MEDICAL, INC.
8.3.4.1. OVERVIEW
8.3.4.2. PRODUCT PORTFOLIO
8.3.4.3. SCOT ANALYSIS
8.3.4.4. STRATEGIC ANALYSIS
8.3.5. DAVOL INC.
8.3.5.1. OVERVIEW
8.3.5.2. PRODUCT PORTFOLIO
8.3.5.3. SCOT ANALYSIS
8.3.5.4. STRATEGIC ANALYSIS
8.3.6. TELEFLEX INCORPORATED
8.3.6.1. OVERVIEW
8.3.6.2. PRODUCT PORTFOLIO
8.3.6.3. STRATEGIC INITIATIVES
8.3.6.4. SCOT ANALYSIS
8.3.6.5. STRATEGIC ANALYSIS
8.3.7. UTAH MEDICAL PRODUCTS, INC.
8.3.7.1. OVERVIEW
8.3.7.2. PRODUCT PORTFOLIO
8.3.7.3. SCOT ANALYSIS
8.3.7.4. STRATEGIC ANALYSIS
8.3.8. BECTON DICKINSON AND COMPANY
8.3.8.1. OVERVIEW
8.3.8.2. PRODUCT PORTFOLIO
8.3.8.3. STRATEGIC INITIATIVES
8.3.8.4. SCOT ANALYSIS
8.3.8.5. STRATEGIC ANALYSIS
8.3.9. GE HEALTHCARE
8.3.9.1. OVERVIEW
8.3.9.2. PRODUCT PORTFOLIO
8.3.9.3. SCOT ANALYSIS
8.3.9.4. STRATEGIC ANALYSIS
8.3.10. PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH)
8.3.10.1. OVERVIEW
8.3.10.2. PRODUCT PORTFOLIO
8.3.10.3. SCOT ANALYSIS
8.3.10.4. STRATEGIC ANALYSIS
8.3.11. ZOEX NIASG
8.3.11.1. OVERVIEW
8.3.11.2. PRODUCT PORTFOLIO
8.3.11.3. SCOT ANALYSIS
8.3.11.4. STRATEGIC ANALYSIS
8.3.12. INPRESS TECHNOLOGIES
8.3.12.1. OVERVIEW
8.3.12.2. PRODUCT PORTFOLIO
8.3.12.3. SCOT ANALYSIS
8.3.12.4. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY GEOGRAPHY 2017-2025
TABLE 2 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($MILLION)
TABLE 3 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN UTERINE BALLOON TAMPONADE BY REGION 2017-2025 ($ MILLION)
TABLE 4 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN FOLEY CATHETERS BY REGION 2017-2025 ($ MILLION)
TABLE 5 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS BY REGION 2017-2025 ($ MILLION)
TABLE 6 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN OTHERS MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 7 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT MARKET IN UNIJECT PREFILLED INJECTION SYSTEM BY REGION 2017-2025 ($ MILLION)
TABLE 8 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN NONPNEUMATIC ANTI-SHOCK GARMENT BY REGION 2017-2025 ($ MILLION)
TABLE 9 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 10 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 11 EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 12 ASIA PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 13 REST OF THE WORLD POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY TYPE 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET
FIGURE 3 RISK FACTORS IN POSTPARTUM HEMORRHAGE
FIGURE 4 COVERAGE OF MATERNAL HEALTH SERVICES
FIGURE 5 CAUSES OF MATERNAL DEATH
FIGURE 6 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY FOLEY CATHETERS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT MARKET BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
FIGURE 12 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 13 UNITED STATES POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 14 CANADA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 15 EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 16 UNITED KINGDOM POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 17 FRANCE POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 18 GERMANY POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 19 SPAIN POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 20 ITALY POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 21 ROE POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 22 ASIA PACIFIC POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 23 INDIA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 24 CHINA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 25 JAPAN POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 26 SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 27 ROAPAC GLOBAL POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 28 REST OF THE WORLD GLOBAL POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 29 LATIN AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 30 MENA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 31 REST OF AFRICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 32 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. MARKET DRIVERS
4.2.1. RISING AWARENESS AMONG PEOPLE IN DEVELOPING COUNTRIES FOR POSTPARTUM TREATMENT
4.2.2. RISING OCCURRENCE OF POSTPARTUM HEMORRHAGE
4.2.3. PROLIFERATION IN POSTPARTUM HEMORRHAGE RISK FACTORS
4.2.4. INCREASING GOVERNMENT EDUCATIONAL INITIATIVES AND TRAINING ABOUT WOMEN’S HEALTH
4.3. MARKET RESTRAINTS
4.3.1. PEOPLE ARE RELUCTANT TO ADOPT UNCONVENTIONAL POSTPARTUM HEMORRHAGE PREVENTIVE DEVICES
4.4. MARKET OPPORTUNITIES
4.4.1. RISING DEMAND FROM EMERGING COUNTRIES
4.4.2. TECHNOLOGICAL ADVANCEMENTS
4.5. MARKET CHALLENGES
4.5.1. LOW ACCEPTANCE OF DEVICES IN DEVELOPING COUNTRIES
4.5.2. LACK OF PRODUCT AWARENESS IN UNTAPPED MARKET
4.5.3. EASY AVAILABILITY OF DRUGS IN THE MARKET
5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($ MILLION)
5.1. BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
5.1.1. GLOBAL FOLEY CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.2. GLOBAL CONDOM CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.3. GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)
5.2. BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
5.3. BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.2.1. PRICING
6.2.2. AVAILABILITY
6.2.3. QUALITY
6.2.4. SPECIFICITY
6.3. OPPORTUNITY MATRIX
6.4. VENDOR LANDSCAPE
7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANAD
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. FRANCE
7.2.3. GERMANY
7.2.4. SPAIN
7.2.5. ITALY
7.2.6. ROE
7.3. ASIA PACIFIC
7.3.1. INDIA
7.3.2. CHINA
7.3.3. JAPAN
7.3.4. SOUTH KOREA
7.3.5. ROAPAC
7.4. REST OF THE WORLD
7.4.1. LATIN AMERICA
7.4.2. MENA
7.4.3. REST OF AFRICA
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. LIST OF STRAGETIC INITIATIVES
8.3. COMPANY PROFILES
8.3.1. 3RD STONE DESIGN, INC.
8.3.1.1. OVERVIEW
8.3.1.2. PRODUCT PORTFOLIO:
8.3.1.3. SCOT ANALYSIS
8.3.1.4. STRATEGIC ANALYSIS
8.3.2. BACTIGUARD AB
8.3.2.1. OVERVIEW
8.3.2.2. PRODUCT PORTFOLIO:
8.3.2.3. STRATEGIC INITIATIVES:
8.3.2.4. SCOT ANALYSIS
8.3.2.5. STRATEGIC ANALYSIS
8.3.3. C. R. BARD, INC.
8.3.3.1. OVERVIEW
8.3.3.2. PRODUCT PORTFOLIO
8.3.3.3. STRATEGIC INITIATIVES:
8.3.3.4. SCOT ANALYSIS
8.3.3.5. STRATEGIC ANALYSIS
8.3.4. COOK MEDICAL, INC.
8.3.4.1. OVERVIEW
8.3.4.2. PRODUCT PORTFOLIO
8.3.4.3. SCOT ANALYSIS
8.3.4.4. STRATEGIC ANALYSIS
8.3.5. DAVOL INC.
8.3.5.1. OVERVIEW
8.3.5.2. PRODUCT PORTFOLIO
8.3.5.3. SCOT ANALYSIS
8.3.5.4. STRATEGIC ANALYSIS
8.3.6. TELEFLEX INCORPORATED
8.3.6.1. OVERVIEW
8.3.6.2. PRODUCT PORTFOLIO
8.3.6.3. STRATEGIC INITIATIVES
8.3.6.4. SCOT ANALYSIS
8.3.6.5. STRATEGIC ANALYSIS
8.3.7. UTAH MEDICAL PRODUCTS, INC.
8.3.7.1. OVERVIEW
8.3.7.2. PRODUCT PORTFOLIO
8.3.7.3. SCOT ANALYSIS
8.3.7.4. STRATEGIC ANALYSIS
8.3.8. BECTON DICKINSON AND COMPANY
8.3.8.1. OVERVIEW
8.3.8.2. PRODUCT PORTFOLIO
8.3.8.3. STRATEGIC INITIATIVES
8.3.8.4. SCOT ANALYSIS
8.3.8.5. STRATEGIC ANALYSIS
8.3.9. GE HEALTHCARE
8.3.9.1. OVERVIEW
8.3.9.2. PRODUCT PORTFOLIO
8.3.9.3. SCOT ANALYSIS
8.3.9.4. STRATEGIC ANALYSIS
8.3.10. PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH)
8.3.10.1. OVERVIEW
8.3.10.2. PRODUCT PORTFOLIO
8.3.10.3. SCOT ANALYSIS
8.3.10.4. STRATEGIC ANALYSIS
8.3.11. ZOEX NIASG
8.3.11.1. OVERVIEW
8.3.11.2. PRODUCT PORTFOLIO
8.3.11.3. SCOT ANALYSIS
8.3.11.4. STRATEGIC ANALYSIS
8.3.12. INPRESS TECHNOLOGIES
8.3.12.1. OVERVIEW
8.3.12.2. PRODUCT PORTFOLIO
8.3.12.3. SCOT ANALYSIS
8.3.12.4. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY GEOGRAPHY 2017-2025
TABLE 2 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($MILLION)
TABLE 3 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN UTERINE BALLOON TAMPONADE BY REGION 2017-2025 ($ MILLION)
TABLE 4 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN FOLEY CATHETERS BY REGION 2017-2025 ($ MILLION)
TABLE 5 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS BY REGION 2017-2025 ($ MILLION)
TABLE 6 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN OTHERS MARKET BY REGION 2017-2025 ($ MILLION)
TABLE 7 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT MARKET IN UNIJECT PREFILLED INJECTION SYSTEM BY REGION 2017-2025 ($ MILLION)
TABLE 8 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN NONPNEUMATIC ANTI-SHOCK GARMENT BY REGION 2017-2025 ($ MILLION)
TABLE 9 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
TABLE 10 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 11 EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 12 ASIA PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
TABLE 13 REST OF THE WORLD POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY TYPE 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET
FIGURE 3 RISK FACTORS IN POSTPARTUM HEMORRHAGE
FIGURE 4 COVERAGE OF MATERNAL HEALTH SERVICES
FIGURE 5 CAUSES OF MATERNAL DEATH
FIGURE 6 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
FIGURE 7 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY FOLEY CATHETERS 2017-2025 ($ MILLION)
FIGURE 8 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS 2017-2025 ($ MILLION)
FIGURE 9 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE 10 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT MARKET BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
FIGURE 11 GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
FIGURE 12 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 13 UNITED STATES POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 14 CANADA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 15 EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 16 UNITED KINGDOM POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 17 FRANCE POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 18 GERMANY POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 19 SPAIN POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 20 ITALY POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 21 ROE POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 22 ASIA PACIFIC POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 23 INDIA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 24 CHINA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 25 JAPAN POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 26 SOUTH KOREA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 27 ROAPAC GLOBAL POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 28 REST OF THE WORLD GLOBAL POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 29 LATIN AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 30 MENA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 31 REST OF AFRICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 32 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
